AI Semiconductor Technologies Blockchain for Healthcare Data and Self-Driving Vehicle Prioritization
IPWatchdog has released its annual list of the top technologies from the patents issued by the U.S. Patent and Trademark Office this year. This year’s list is dominated by semiconductor technologies, reflecting their importance to the global economy. This year’s list highlights another recurring theme: artificial intelligence. It often intersects microprocessor innovation. Some of the selections this year reflect the uncertainty of patent law, which could threaten some of the patents below.
#1 : U.S. The Intelligent FODAS system and method based on AI chip, 11875246 represents an important AI application that has broad use scenarios. It also represents the rise of China’s role as a major innovator of fundamental technologies. The ‘246 Patent, issued in January, was awarded to Sichuan Guangsheng IOT Technology, based in China’s Chengdu High-Tech Zone. It claims an advancement to distributed optical fibre sensing technologies that improve oil and gas exploration, warning systems for weather disasters, and military combat. The claimed invention provides ultra precise real-time monitoring of long-distance networks by addressing constraints faced by central processing units (CPUs) under the parallel processing demands of AI algorithms.
#2: U.S. Patent No. 11895219, Artificial Intelligence Calculation Semiconductor Device and Storage Device Comprising the Same
Improvements to hardware powering AI applications are disclosed by the ‘219 patent, issued in February to Korean tech conglomerate Samsung Electronics, which has overtaken IBM as the top U.S. patent recipient in recent years. The ‘219 Patent claims an AI calculation device with a multiply and accumulater calculator that performs homomorphic cryptography by generating a second cipher text, performing cyclic shifting to obtain a number of rotated texts, and performing multiplication, addition, and subtraction calculations on these rotated texts. The rotation of the cipher texts reduces the amount of calculations required to perform homomorphic encryption by enabling simple matrix multiplication techniques.
#3: U.S. Patent No. 12143380, Nullifying Biometrics
Many financial services companies expect that the use of biometric identifiers for secure authorization techniques will eventually replace traditional passwords. The third-placed ‘380 patent was issued to American telecom giant AT&T in November. It claims a technology that provides an impermanent, biometric to address system recognition failures. The claimed system determines the expiration of a biometric nullifying image and decides whether to deny authentication based on natural physiological processes associated to the nullifying image. The preferred embodiments of the invention are machine-readable barcodes that can be printed on human hair or nail plates, with the expiration rate determined by natural growth rates.
#4 : U.S. 11965177, Method of Manufacturing Dual-Specific T-Cells for Use in Cancer Immunotherapy
Modern medicine has made great inroads against cancer through the use of patient immunotherapies. The Versiti blood research institute foundation of Milwaukee, WI was granted the ‘177 Patent in April. It claims a population of autologous, dual-specific lymphocytes that are isolated from a patient’s blood and express an endogenous antigen receptor. The technology improves the effectiveness of adoptive cell transfer against solid tumors, which exhibit a immunosuppressive microenvironment and reduced T cell migration.
#5: U.S. Patent No. 11984205, Non-Fungible Token Systems and Methods for Storing and Accessing Healthcare Data
Blockchain technologies are again in focus with the price of bitcoin soaring past $100,000 USD. Carlsmed, a medical technology developer from Carlsbad, CA was granted the ‘205 Patent in May. The patent claims a blockchain enabled medical implant, along with systems and methods to store and access healthcare data in blockchain managed digital filing cabinets. The claimed medical device includes a proximity communication element and a memory that stores a private key, allowing an external device access to electronic medical records from a distributed ledger. The use of blockchain-enabled implant allows for the recovery of data in the event of an accident, while improving security of patient records. 12073720, Vehicle-to-Vehicle Payment System for Traffic Prioritization in Self-Driving Vehicles
Independent inventors are a critical if small portion of the American innovator community and the sixth-place ‘720 patent issued to Matthew Roy of Montreal, Canada, this August claims an intriguing method of prioritizing traffic for the coming advent of autonomous vehicles. The claimed vehicle has a processor that works with a radiofrequency transceiver in order to receive a traffic priority price determined by a central computer that facilitates transactions. Unfortunately, the claimed advance leverages a range of navigational and imaging tools already used by self-driving cars, leaving questions as to whether this and other granted patents on this list would survive a validity challenge under current Section 101 jurisprudence.
#7: U.S. Patent No. 12061999, Systems and Methods for Automated Damage Estimation
The ‘999 patent, issued to insurance provider United States Automobile Association in August, is another example of a technology solving industry problems that could face validity issues under current Section 101 law. This patent claims a computer-readable medium containing instructions that can generate a virtual environment based on pre-event images, an inventory list of items identified in the model with a value above a threshold amount and a comparison report showing a change in inventory items’ state and a loss estimation. The U.S. Patent Number. The patent number 12070912, which uses expanded and hydrophobic popcorn to produce three-dimensional shaped parts, is a result of materials engineering at Germany’s University of Gottingen. It was developed for the creation of lightweight, flexible molded products with better recycling characteristics and less flammability than plastics. The patent ‘912 was issued in August and claims a molded product made from a compound consisting of popcorn particles that are 95% surrounded by a polymer hydrophobic and a binder. This invention also includes quinoa, wheat, amaranth and puffed corn. 11883031, Device for Restricting Blood Flow to Aneurysms
Brain aneurysms are very difficult to detect and can impact people of any age. Issued in January to Israeli medical technology developer EndoStream, the ‘031 patent claims a device configured to cover an orifice of a vascular malformation to restrict blood flow, fostering gradual healing of an aneurysm while preventing recanalization, which occurs in about 30% of aneurysms.
#10: U.S. Patent No. The ‘031 patent was issued to Israeli medical technology developer EndoStream in January. It claims a device configured to cover an orifice of a vascular malformation to restrict blood flow, fostering gradual healing of aneurysms while preventing recanalization, which occurs in about 30% of aneurysms. Issued to Japanese conglomerate Shin-Etsu Chemical, the ‘517 patent claims a silicone composition including organopolysiloxane pre-ceramic polymer, an organohydrogenpolysiloxane cross-linking agent and a catalyst for adding silicone-hydrogen to unsaturated bonds.
#11: U.S. Patent No. 12084672, Genetically Engineered Land Plants That Express an Increased Seed Yield Protein and/or an Increased Seed Yield RNA
Government projections show demand for food increasing across the world over the next few decades due to both population growth and increasing incomes. The patent ‘672, issued in September to Woburn, MA-based Yield10 Bioscience, claims a genetically modified land plant with an increased expression of a specific protein to promote a higher seed, tuber, and fruit yield. The invention uses proteins that are already present in food and oilseed plants to overcome the challenges associated with regulatory approval and social acceptability of transgenic organisms. Regulatory approval for a single GMO trait can cost in excess of $100 million, according to the ‘672 patent’s specification.
#12: U.S. Patent No. 12154060, UAV Facility
Drone delivery services could enable retailers to reach many more customers, but the complexity of such services increases with the volume of shipments. The ‘060 Patent was granted to Flirtey Holdings in Reno, NV for its unmanned aerial vehicle facility with a detector system identifying delivery consignments using an identification code indicating the physical characteristics of a load. The identification code not only ensures accuracy of good delivery but can improve the handling of sensitive shipments or those with potentially harmful contents.
Image Source: Deposit Photos
Author: lipmic
Image ID: 36013207
